New treatments for vaccine-associated cancer are desperately needed. Investigations have recently begun to evaluate the role of radiation therapy and chemotherapy for these cancers with encouraging results, yet many still reoccur. Recently a new drug (ST1571) that targets a specific growth factor of these cancer cells (platelet-derived growth factor – PDGF) has been shown to increase the benefits of chemotherapy. This new study hopes to prove this drug (ST1571) will also increase the efficacy and benefits of radiotherapy as well.
Grants